CCTN-CONTRACEPTIVE DEVELOPMENT PROGRAM-NICHD CONTRACEPTIVE CLINICAL TRIALS NETWORK-FEMALE SITES-CORE FUNCTION ACTIVITIES

需要一种新的避孕方法，既能有效预防意外怀孕，又能降低静脉血栓形成的风险。 (VTE)，特别是对于肥胖女性。避孕临床试验网络(CCTN)的使命是制定方案和进行临床试验，以协助产品开发，最终目标是为妇女提供有效和安全的避孕措施。 尤尼斯·肯尼迪·施莱弗国家儿童健康和人类发展研究所(NICHD)的使命是为妇女开发安全有效的避孕药具，包括肥胖妇女和患有目前避孕药禁忌的医疗条件的妇女。

There is a demand for new methods of contraception that can provide effective protection against unintended pregnancy as well as reduce the risk of venous thromboembolism (VTE), particularly for obese women. The mission of the Contraceptive Clinical Trials Network (CCTN) is to develop protocols and conduct clinical trials that will assist in product development with the end goal to provide effective and safe contraception for women. The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) has a mission to develop safe and effective contraceptives for women, including obese women and women who have medical conditions for which current contraceptive products are contraindicated.